Search

ENANTA PHARMACEUTICALS INC

Отворен

СекторЗдравеопазване

13.99 -0.07

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

13.57

Максимум

14.65

Ключови измерители

By Trading Economics

Приходи

-6.4M

-20M

Продажби

-2.8M

14M

EPS

-0.67

Марж на печалбата

-135.81

Служители

120

EBITDA

-6.8M

-15M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+41.84% upside

Дивиденти

By Acuity

Следващи печалби

13.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-27M

374M

Предишно отваряне

14.06

Предишно затваряне

13.99

Настроения в новините

By Acuity

71%

29%

311 / 340 Класиране в Healthcare

ENANTA PHARMACEUTICALS INC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.08.2026 г., 19:06 ч. UTC

News

Enanta Pharmaceuticals is rising despite recent downgrades, remaining above its 20-day moving average. HC Wainwright maintains a "buy" rating with a $20 target.

21.08.2026 г., 19:41 ч. UTC

Enanta Pharmaceuticals is trading higher, supported by gains in biotechnology stocks. The asset remains above its 20-day moving average during Friday's session.

20.08.2026 г., 19:31 ч. UTC

Enanta Pharmaceuticals Inc. shares are lower today amid pressure on biotechnology stocks, continuing a decline since Wednesday's close. No specific news was identified.

18.08.2026 г., 19:16 ч. UTC

Enanta Pharmaceuticals is trading higher today, supported by a rally in the Biotechnology sub-sector. Shares have gained since Monday's close.

17.08.2026 г., 20:06 ч. UTC

Enanta Pharmaceuticals Inc shares are lower today, continuing a decline since Friday amid broader market weakness following a drop in U.S. retail sales.

14.08.2026 г., 20:06 ч. UTC

Enanta Pharmaceuticals is trading lower amid mixed market sentiment following a reported decline in U.S. retail sales for July.

13.08.2026 г., 19:36 ч. UTC

Enanta Pharmaceuticals Inc is trading higher, remaining above its 20-day moving average, despite no specific company news identified for the price movement.

11.08.2026 г., 20:06 ч. UTC

Enanta Pharmaceuticals Inc shares are lower today, reflecting broader market declines. The stock reached a session low earlier but has since recovered slightly.

5.08.2026 г., 19:46 ч. UTC

Enanta Pharmaceuticals Inc shares are lower, reflecting broader market sentiment amid disappointing ADP employment data showing a rise of only 44,000 jobs in July.

4.08.2026 г., 19:46 ч. UTC

Enanta Pharmaceuticals Inc shares are higher, buoyed by a decline in crude oil prices that eases inflation concerns. No specific company news was identified.

3.08.2026 г., 19:23 ч. UTC

Enanta Pharmaceuticals Inc shares are rising amid a broader market rally, supported by gains in major technology stocks and renewed investor confidence.

31.07.2026 г., 20:06 ч. UTC

Enanta Pharmaceuticals Inc's shares are lower today, continuing a downward trend amid rising U.S. Treasury yields and crude oil prices. No specific news was identified.

30.07.2026 г., 19:45 ч. UTC

Enanta Pharmaceuticals Inc. is advancing, supported by broader market gains. Earlier in the session, shares pulled back from a session high.

29.07.2026 г., 18:26 ч. UTC

Enanta Pharmaceuticals Inc is declining in Wednesday's session, marking the seventh consecutive day of lower prices. No specific news has been identified to explain the movement.

28.07.2026 г., 20:06 ч. UTC

Enanta Pharmaceuticals Inc is declining, marking five consecutive sessions lower. The stock peaked earlier but has since pulled back amid broader market pressures.

27.07.2026 г., 18:36 ч. UTC

Enanta Pharmaceuticals Inc is higher today, building on Friday's momentum amid broader market dynamics following a decline in oil prices.

24.07.2026 г., 20:06 ч. UTC

Enanta Pharmaceuticals Inc. shares are lower today, reversing from a recent trend of higher daily closes since Thursday's close.

21.07.2026 г., 19:31 ч. UTC

Enanta Pharmaceuticals is rising during Tuesday's session, reflecting broader market strength and positive sentiment from recent earnings reports by General Motors and Novartis.

20.07.2026 г., 19:46 ч. UTC

Enanta Pharmaceuticals Inc shares are lower today, continuing a decline since Friday's close. The stock has shown significant volatility during the session.

Сравнение с други в отрасъла

Ценова промяна

ENANTA PHARMACEUTICALS INC Прогноза

Ценова цел

By TipRanks

41.84% нагоре

12-месечна прогноза

Среден 20 USD  41.84%

Висок 20 USD

Нисък 20 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за ENANTA PHARMACEUTICALS INC през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

1

Купи

0

Задържане

0

Продай

Настроение

By Acuity

311 / 340 Класиране в Здравеопазване

Настроения в новините

Мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно ENANTA PHARMACEUTICALS INC

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. The company has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. Enanta Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
help-icon Live chat